Reviva Pharmaceuticals Holdings, Inc. Income Taxes Paid
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Income Taxes Paid of $675 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-12
- Reviva Pharmaceuticals Holdings, Inc. income taxes paid for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. income taxes paid for the quarter ending 2026-03-31 was $675.00, a 37.21% decline year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. income taxes paid for the quarter ending 2025-12-31 was $0.00.
- Reviva Pharmaceuticals Holdings, Inc. income taxes paid for the quarter ending 2025-09-30 was $0.00.
- Reviva Pharmaceuticals Holdings, Inc. income taxes paid for fiscal 2025 was $3.37K, a 1.40% decline from fiscal 2024.
- Reviva Pharmaceuticals Holdings, Inc. income taxes paid for fiscal 2024 was $3.42K, a 82.70% decline from fiscal 2023.
- Reviva Pharmaceuticals Holdings, Inc. income taxes paid for fiscal 2023 was $19.75K, a 19.84% increase from fiscal 2022.
- Reviva Pharmaceuticals Holdings, Inc. income taxes paid for fiscal 2022 was $16.48K, a 586.83% increase from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $675.00 10-Q · filed 2026-08-12 | $675.00 derived: sum of 3 quarters · filed 2026-08-12 | $675.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $675.00 10-Q · filed 2026-05-13 | $675.00 derived: sum of 2 quarters · filed 2026-05-13 | $675.00 derived: sum of 3 quarters · filed 2026-05-13 | $2.97K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $2.29K derived: sum of 3 quarters · filed 2026-08-12 | $3.37K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.29K derived: sum of 2 quarters · filed 2026-08-12 | $3.37K 10-Q · filed 2025-11-13 | $3.37K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $2.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $3.37K 10-Q · filed 2026-08-12 | $3.37K derived: sum of 3 quarters · filed 2026-08-12 | $3.37K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.07K 10-Q · filed 2026-05-13 | $1.07K derived: sum of 2 quarters · filed 2026-05-13 | $1.07K derived: sum of 3 quarters · filed 2026-05-13 | $3.83K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $2.76K derived: sum of 3 quarters · filed 2026-03-30 | $3.42K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.76K derived: sum of 2 quarters · filed 2025-11-13 | $3.42K 10-Q · filed 2025-11-13 | $4.50K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $3.42K 10-Q · filed 2025-08-14 | $4.50K derived: sum of 3 quarters · filed 2025-08-14 | $19.23K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $657.00 10-Q · filed 2025-05-15 | $1.74K derived: sum of 2 quarters · filed 2025-05-15 | $16.47K derived: sum of 3 quarters · filed 2025-05-15 | $18.17K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.08K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | $15.81K derived: sum of 2 quarters · filed 2025-04-03 | $17.51K derived: sum of 3 quarters · filed 2025-04-03 | $19.75K 10-K · filed 2025-04-03 |
| 2023-09-30 | $14.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $16.43K derived: sum of 2 quarters · filed 2024-11-14 | $18.67K 10-Q · filed 2024-11-14 | $30.18K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $3.94K 10-Q · filed 2024-08-14 | $15.44K derived: sum of 3 quarters · filed 2024-08-14 | $16.44K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $2.24K 10-Q · filed 2024-05-14 | $13.74K derived: sum of 2 quarters · filed 2024-05-14 | $14.74K derived: sum of 3 quarters · filed 2024-05-14 | $18.05K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $11.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $12.50K derived: sum of 2 quarters · filed 2024-04-15 | $15.81K derived: sum of 3 quarters · filed 2024-04-15 | $16.48K 10-K · filed 2024-04-15 |
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $4.31K derived: sum of 2 quarters · filed 2023-11-14 | $4.98K 10-Q · filed 2023-11-14 | $4.98K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $3.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.98K 10-Q · filed 2023-08-14 | $3.98K derived: sum of 3 quarters · filed 2023-08-14 | $4.78K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $675.00 10-Q · filed 2023-05-15 | $675.00 derived: sum of 2 quarters · filed 2023-05-15 | $1.48K derived: sum of 3 quarters · filed 2023-05-15 | $1.48K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $800.00 derived: sum of 2 quarters · filed 2023-03-30 | $800.00 derived: sum of 3 quarters · filed 2023-03-30 | $2.40K 10-K · filed 2023-03-30 |
| 2021-09-30 | $800.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $800.00 derived: sum of 2 quarters · filed 2022-11-14 | $2.40K 10-Q · filed 2022-11-14 | $3.20K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.60K 10-Q · filed 2022-08-15 | $2.40K derived: sum of 3 quarters · filed 2022-08-15 | $2.40K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.60K 10-Q · filed 2022-05-16 | $2.40K derived: sum of 2 quarters · filed 2022-05-16 | $2.40K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $800.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $800.00 derived: sum of 2 quarters · filed 2022-03-15 | $800.00 10-K · filed 2022-03-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | $800.00 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |